The American Journal of Managed Care

Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL

Flow cytometry offers practical advantages for real-time monitoring of CAR T cell expansion, persistence, and toxicity risk in aggressive large B-cell lymphoma patients. Early CAR T cell expansion is ...
Labroots

Helpless Not Hopeless: Applying Cell Sorting And High-Dimensional Flow Cytometry For Long-Term Characterization Of Murine Pathogen-Specific CD8+ T Cells

Instructor, Marc and Jennifer Lipschultz Precision Immunology Institute and Department of Immunology and Immunotherapy at the Icahn School of Mount Sinai The generation of durable CD8+ T cell memory ...
2 Minute Medicine

Chimeric antigen receptor T-cell therapy may induce sustained remission in multirefractory autoimmune hemolytic anemia

In this prospective cohort study, CD19-directed chimeric antigen receptor (CAR) T-cell therapy was found to elicit a complete ...
GEN

Cell Surface Marker Profiling with Spectral Cytometry Optimizes CAR T Manufacturing

Not all patients respond well to chimeric antigen receptor (CAR) T cell therapies, which reprogram a patient’s own immune cells to recognize and attack cancer. A way to optimize these treatments is to ...
Labroots

Determination Of Cell Surface Markers On Circulating Immune Cells As Biomarkers For Disease Monitoring Using Spectral Flow Cytometry

The identification of reliable biomarkers from peripheral blood is crucial for improving disease diagnosis and monitoring. Spectral flow cytometry has emerged as a powerful tool for high-dimensional ...